Exelixis, Inc. (NASDAQ:EXEL) released that the enrollment target of 650 patients has been reached for METEOR, the company's phase 3 pivotal examination of cabozantinib and that top-line efficacy and safety data from METEOR are now expected in the second quarter of 2015. \ On the other consideration, Exelixis, Inc. (NASDAQ:EXEL) begun last trade with a price of $1.74 and throughout the trading session climbed at $1.75. The day-trade ended with a decrease of -1.76% to closed at $1.67. The stock is going forward its fifty-two week low with 23.70% and lagging behind from its 52 week high price with -80.14%. EXEL last month stock price volatility remained 6.31%.Centura Health and DaVita HealthCare Partners Inc. (NYSE:DVA) released that a new JV that will propose a separated health care delivery model to help optimize health care value and lower costs for consumers in Colorado and Kansas. DaVita HealthCare Partners Inc. (NYSE:DVA) stock hit highest price at $78.07, beginning with a price of $77.45 to the closed at 78.03 by an advance of 0.67% with a day range of $77.15-$78.07. The total market capitalization remained 16.761 Billion, total volume of 1.15 Million shares held in the session was surprisingly higher than its average volume of 787.78 shares.Ericsson (NASDAQ:ERIC) released that it has enlarged its relationship with Far EasTone in Taiwan, and serves as the prime integrator for the lead-to- service domain of the mobile operator's IT transformation. Shares of Ericsson (NASDAQ:ERIC) opened at $12.02 with 3270.59 million outstanding shares and hit to its highest price of $12.04 during the day and finally closed at $11.93 by scoring 1.62%. In the whole session, it traded on volume of 2.44 Million shares, which turned higher than its average volume.
Discover Hidden Gems
Don't miss the next big opportunity. Subscribe for timely alerts on potential market movers.
